Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study
Clinical trial NCT02520245 · WITHDRAWN
Trial details
- NCT number
- NCT02520245
- Sponsor
- Regeneron Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2023-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.